Virtual Reality-enhanced Exercise and Education in Cardiac Rehabilitation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03945201 |
Recruitment Status :
Completed
First Posted : May 10, 2019
Last Update Posted : August 2, 2019
|
Sponsor:
Thomas Jefferson University
Information provided by (Responsible Party):
Thomas Jefferson University
Tracking Information | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | May 8, 2019 | ||||||||||
First Posted Date ICMJE | May 10, 2019 | ||||||||||
Last Update Posted Date | August 2, 2019 | ||||||||||
Actual Study Start Date ICMJE | January 29, 2018 | ||||||||||
Actual Primary Completion Date | May 31, 2019 (Final data collection date for primary outcome measure) | ||||||||||
Current Primary Outcome Measures ICMJE |
Comparison of Participant 6-minute Walk Test Improvement Between Control and Intervention Groups [ Time Frame: From date of enrollment through study completion, an average of 12 weeks ] Each participant will complete a 6MWT at both their first and last cardiac rehab treatment sessions. Distance improvement between first and last treatment session is expected for all participants. Average distance improvement (measured in feet) between study arms will be compared to evaluate effectiveness of interventions.
|
||||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||||
Change History | |||||||||||
Current Secondary Outcome Measures ICMJE |
|
||||||||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||||
Descriptive Information | |||||||||||
Brief Title ICMJE | Virtual Reality-enhanced Exercise and Education in Cardiac Rehabilitation | ||||||||||
Official Title ICMJE | Effect of a Virtual Reality-enhanced Exercise and Education Intervention on Patient Engagement and Learning in Cardiac Rehabilitation | ||||||||||
Brief Summary | This study incorporates a virtual reality (VR) simulated walking environment, with audio component of patient education, into the treadmill portion of outpatient cardiac rehabilitation (CR). The VR program was developed by Plas.MD and is named Bionautica Trails. | ||||||||||
Detailed Description | Not Provided | ||||||||||
Study Type ICMJE | Interventional | ||||||||||
Study Phase ICMJE | Not Applicable | ||||||||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Participant) Masking Description: Consent and enrollment process does not mention virtual reality to maintain blinding between control and intervention arms. Primary Purpose: Other
|
||||||||||
Condition ICMJE |
|
||||||||||
Intervention ICMJE |
|
||||||||||
Study Arms ICMJE |
|
||||||||||
Publications * |
|
||||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||
Recruitment Information | |||||||||||
Recruitment Status ICMJE | Completed | ||||||||||
Actual Enrollment ICMJE |
72 | ||||||||||
Original Actual Enrollment ICMJE | Same as current | ||||||||||
Actual Study Completion Date ICMJE | July 29, 2019 | ||||||||||
Actual Primary Completion Date | May 31, 2019 (Final data collection date for primary outcome measure) | ||||||||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||||
Sex/Gender ICMJE |
|
||||||||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||||||||
Accepts Healthy Volunteers ICMJE | No | ||||||||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||||
Listed Location Countries ICMJE | United States | ||||||||||
Removed Location Countries | |||||||||||
Administrative Information | |||||||||||
NCT Number ICMJE | NCT03945201 | ||||||||||
Other Study ID Numbers ICMJE | 17P.652 | ||||||||||
Has Data Monitoring Committee | No | ||||||||||
U.S. FDA-regulated Product |
|
||||||||||
IPD Sharing Statement ICMJE |
|
||||||||||
Current Responsible Party | Thomas Jefferson University | ||||||||||
Original Responsible Party | Same as current | ||||||||||
Current Study Sponsor ICMJE | Thomas Jefferson University | ||||||||||
Original Study Sponsor ICMJE | Same as current | ||||||||||
Collaborators ICMJE | Not Provided | ||||||||||
Investigators ICMJE | Not Provided | ||||||||||
PRS Account | Thomas Jefferson University | ||||||||||
Verification Date | August 2019 | ||||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |